HIV drugs Stories

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
Reuters  |  Mar 29, 2025

U.S. District Judge Zahid Quraishi in Trenton, New Jersey, ordered the drugmaker's Janssen unit to pay $360 million for violating the federal False Cl...

KEMSA releases ARVs targeting one million HIV patients after concerns over US aid cuts
KEMSA releases ARVs targeting one million HIV patients after concerns over US aid cuts
Maureen Kinyanjui  |  Mar 15, 2025

The supplies will be distributed through a partnership with the Mission for Essential Drugs and Supplies, ensuring their efficient delivery to those i...

Experts raise concerns over side effects of HIV medication in women
Experts raise concerns over side effects of HIV medication in women
Maureen Kinyanjui  |  Feb 28, 2025

Kenya's HIV milestone: Transition to DTG and strides in treatment
Kenya's HIV milestone: Transition to DTG and strides in treatment
Charity Kilei  |  Jan 17, 2025

Mother-to-child HIV transmission rates in Kenya drop, but challenges remain
Mother-to-child HIV transmission rates in Kenya drop, but challenges remain
Maureen Kinyanjui  |  Nov 21, 2024

Despite this progress, experts warn that the current rates are still too high.

HIV prevention drug expected to be launched in Kenya next year
HIV prevention drug expected to be launched in Kenya next year
Maureen Kinyanjui  |  Oct 05, 2024

The drug, lenacapavir, is administered via an injection twice a year.

Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.